about
Preoperative blood transfusions for sickle cell diseaseFolate supplementation in people with sickle cell diseaseRed blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviewsLow-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell diseaseInterventions for treating intrahepatic cholestasis in people with sickle cell diseaseInterventions for treating leg ulcers in people with sickle cell diseaseAgents for inhibiting the adhesion of red blood cells to the endothelium in people with sickle cell diseaseMagnesium for treating sickle cell diseaseInterventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complicationsInterventions for caregivers for the recognition of disease-related complications in children with sickle cell diseaseAntibiotics for treating community acquired pneumonia in people with sickle cell diseaseLow-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell diseaseInterventions for treating intrahepatic cholestasis in people with sickle cell diseaseInterventions for caregivers for the recognition of disease-related complications in children with sickle cell diseaseLow-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell diseaseBlood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseVitamin D supplementation for sickle cell diseaseInterventions for treating leg ulcers in people with sickle cell diseaseRegular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseaseCustomizing the genome as therapy for the β-hemoglobinopathiesNovel insights in the management of sickle cell disease in childhoodMusculoskeletal Manifestations of Sickle Cell Disease: A ReviewEnvironmental determinants of severity in sickle cell diseaseMusculoskeletal complications of haematological diseaseAn adolescent with sickle cell anaemia experiencing disease-related complications: priapism and leg ulcer--a management challengeNeuroimaging findings in sickle cell diseaseAnemia: progress in molecular mechanisms and therapiesTissue factor and thrombin in sickle cell anemiaUsing formative research to develop a counselor training program for newborn screening in GhanaSickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal responseIdentification of a Small Molecule that Increases Hemoglobin Oxygen Affinity and Reduces SS Erythrocyte SicklingGBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell diseaseNeurogenomics in Africa: Perspectives, progress, possibilities and prioritiesHaemoglobinopathies and the rheumatologistPrevalence of vitamin D deficiency in sickle cell disease: a systematic reviewMorphine for the treatment of pain in sickle cell diseaseInformation exploration system for sickle cell disease and repurposing of hydroxyfasudilPhase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemiaInflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 ProteinSickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In Vivo
P2860
Q24185919-5E59DBD3-0B5E-41DB-B4AC-CD3E79F6DC8CQ24186134-B54BC61C-EDFC-4957-BB8A-853EF26283D3Q24186232-D0C62598-F7C3-4B33-AE7A-4AC90BCDEBF1Q24187057-66699B16-2A46-4E68-A29E-3995AED537CEQ24187279-33AED3EC-4C94-4949-92AA-8D6D272BDC0EQ24187407-F45AA80D-950E-446F-B423-0C72C955FFEAQ24188211-E9BA7CA9-F58F-4806-A83A-3DEA0E135EBAQ24193246-35EC60E1-504E-4EAF-BF54-825F592B5E10Q24194296-E30B5C2D-E761-43FA-AF13-1E9E891BA3B1Q24194460-7850B2E0-D56C-4A0E-98A7-B9BD3EBB7E72Q24197977-1B2CAFC4-B1C3-4ACD-A81D-E5DF2C1BB320Q24198964-330AE21B-29B7-4A9F-9A65-81AB891683FDQ24200803-CC135295-E972-4F3C-A2CB-41FBDA7CD034Q24201854-D11116A3-B37C-46EE-8136-BF8F64C7A9D9Q24201981-DC55725C-3DB7-4B94-BBC8-8F33552C98BBQ24202463-FB37A217-812F-41DB-BEC1-DBA8B7A22FE4Q24202624-C75ECD18-BD8A-4721-B429-C034F0110099Q24202954-EDD56680-D8A2-4475-92E2-04338A8F620EQ26471968-F2718814-A31A-476B-AD2A-66F556C799AAQ26751061-980F8ABA-2CEC-4A77-AA6C-0776B9407F78Q26767015-F852E275-7476-43D1-A2ED-492041A5A0A1Q26775662-2CA62363-2892-4F42-B4F5-56A284F60142Q26784082-26CEC106-6CAC-469A-927A-A4954D2D7719Q26786755-55939799-B8C3-4B03-9CBB-38F2D967B82AQ26823604-A15929AB-17F4-442E-AB42-2AC0484F1D5CQ26825415-D1970FE9-992F-4E39-A9E1-9236520570D5Q27023172-D4A4D8D9-EC5C-4DFA-8BC5-5CFE9C07DB3DQ27024887-7CCC2561-D4D0-4E62-A348-9148475D1387Q27315795-284CD1C4-80DD-4692-B628-E34A76AAFF6DQ27324518-2A240D57-32B9-4359-838E-DEC4C147AE03Q27684817-4E968356-1061-4040-B4AA-14B4D53E4B76Q27716374-5B0E7880-9828-4A84-86D2-5CDDB45BF310Q28075329-D24B6AB4-84A8-4EC1-A60D-42530D890D9CQ28075506-98E5E287-AC91-4653-8C63-AD012194C761Q28081148-81129F4B-058B-43AB-84F8-888A7990EDA8Q28087296-4E9A8406-192C-4730-A120-396B90C17C1EQ28533770-52E859A4-F474-4CE5-871B-1A4DD0E9706AQ28540243-3D0748F7-4945-48C3-9050-6D208BDFF346Q28553088-8848787D-9C7B-4EC6-9900-39381DED1709Q28596621-3BBF7200-6637-49CF-A422-366E52D0B9F9
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Sickle-cell disease.
@ast
Sickle-cell disease.
@en
Sickle-cell disease.
@nl
type
label
Sickle-cell disease.
@ast
Sickle-cell disease.
@en
Sickle-cell disease.
@nl
prefLabel
Sickle-cell disease.
@ast
Sickle-cell disease.
@en
Sickle-cell disease.
@nl
P1433
P1476
Sickle-cell disease.
@en
P2093
David C Rees
P304
P356
10.1016/S0140-6736(10)61029-X
P407
P577
2010-12-03T00:00:00Z